Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NeuBase Therapeutics, Inc. | Chief Financial Officer | Common stock | 84.2K | $162K | $1.92 | Mar 16, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NBSE | NeuBase Therapeutics, Inc. | Mar 16, 2023 | 1 | $0 | 4 | Mar 17, 2023 | Chief Financial Officer |
NBSE | NeuBase Therapeutics, Inc. | Nov 3, 2022 | 1 | $0 | 4 | Nov 4, 2022 | Chief Financial Officer |
NBSE | NeuBase Therapeutics, Inc. | Mar 18, 2022 | 1 | $18.1K | 4 | Mar 21, 2022 | Chief Financial Officer |
NBSE | NeuBase Therapeutics, Inc. | Mar 16, 2022 | 2 | $33.6K | 4 | Mar 18, 2022 | Chief Financial Officer |
NBSE | NeuBase Therapeutics, Inc. | Jan 10, 2022 | 1 | $0 | 4 | Jan 10, 2022 | Chief Financial Officer |
NBSE | NeuBase Therapeutics, Inc. | Jan 10, 2022 | 0 | $0 | 3 | Jan 10, 2022 | Chief Financial Officer |